Last reviewed · How we verify

NCT04170192

Multi-center Clinical Study of Cord Blood Stem Cell Transplantation for IBD Caused by IL-10R Gene Deficiency

Status unknown Last updated 17 February 2020
What this trial tests

trial testing Cord Blood Stem Cell Transplantation in Inflammatory Bowel Diseases in 50 participants. Status unknown.

Timeline
1 December 2019
Primary endpoint
31 October 2022
31 October 2023

Quick facts

Lead sponsorChildren's Hospital of Fudan University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment50
Start date1 December 2019
Primary completion31 October 2022
Estimated completion31 October 2023
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Children's Hospital of Fudan University

Who can join

Adults 1 Month to 18, any sex, with Inflammatory Bowel Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Very early onset inflammatory bowel disease (VEO-IBD) is a special subtype of children's inflammatory bowel disease (IBD). VEO-IBD is mostly caused by single-gene defects and can be cured by allo-hematopoietic stem cell transplantation ( HSCT). Umbilical Cord Blood Transplantation (UCBT) is less reported in these patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Therapeutic potential of gene therapy for gastrointestinal diseases: Advancements and future perspectives.
    Yue NN, Xu HM, Xu J, Zhu MZ, et al · · 2023 · cited 7× · PMID 37663132 · DOI 10.1016/j.omto.2023.08.007

Verify or expand the search:

Other recruiting trials for Inflammatory Bowel Diseases

Currently open trials in the same condition.

Other Children's Hospital of Fudan University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04170192.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing